EverlyWell: At-Home Sample Collection Test Kits

At-Home Do-It-Yourself Kits – $175 Billion Investment Attraction

EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.

EverlyWell At-Home Sample Collection Test Kits

Delivers FDA-approved sampling kits for a vast range of women's health, infertility, allergies, cholesterol, thyroid levels, etc., and provides results after receipt.

For the first time, FDA approved emergency use of COVID-19 test kits, and 75% of products are growing rapidly, showing a growth rate of 100% or more every year.

EverlyWell

EverlyWell develops do-it-yourself kits for a vast range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid, and metabolism among the others, allowing users to perform tests at home and receive physician-reviewed results and insights on their mobile devices. EverlyWell also provides at-home covid testing.

General Information

Headquarters : Austin, TX
Founders : Julia Taylor Cheek
Categories : Health Care, Medical Device, Mobile Apps, Wellness
Founded : 2015
Contact : contact@everlywell.com

Funding

Investors: BlackRock, Foresite Capital, Goodwater Capital, Greenspring Associates, Highland Capital Partners, Lux Capital, Morningside Ventures, Next Coast Ventures, Portfolia, The Chernin Group

Funding Rounds (7) - $325M
Jan 17, 2021 Secondary Market / $75M
Dec 3, 2020 Series D / $175M
Feb 1, 2020 Series C / $25M
Apr 16, 2019 Venture Round / $50M
Oct 4, 2018 Series B
Mar 5, 2017 Seed Round
Feb 4, 2017 Pre Seed Round

1. Reason for attention

In the United States, there is no concept of a comprehensive health checkup, and as a system that provides checkup and treatment for problematic areas, in order to receive a specific test, it is necessary to obtain approval from the attending physician and then separate Make a reservation in the lab and proceed with the inspection

Market where the entire process is quite slow and expensive, such as having to wait a long time again for the results to be confirmed

EverlyWell, a provider of 'home health care kits', is providing innovative services to consumers who are tired of the complicated and expensive health care system by solving this complicated American diagnostic process with test kits.

2. Current business status

EverlyWell provides general users with an FDA-approved 'Home Sampling Test Kit' for women's health, infertility, food and allergy, Lyme disease, cholesterol, testosterone, and thyroid level tests, and even provides digital test result monitoring services.

In particular, in 2020, when COVID-19 was spreading, we launched a ‘home use COVID-19 test kit’ and received emergency use approval from the U.S. Food and Drug Administration for the first time, selling more than 500,000 kits.

Avoidance of face-to-face contact due to the spread of COVID-19 has led to an explosive increase in demand for home digital healthcare options, with three-quarters of EverlyWell's tested products showing growth rates of over 100% and other products growing 4-5 times. is growing rapidly

3. Competition

LetsGetChecked

Founded in Dublin, Ireland in 2014, total funding of $113 million, including $71 million in Series C funding in May 2020
350 employees in the US and Ireland

Thriva

As a British company established in 2015, blood test results can be checked within 48 hours by sending blood at home

4. Future Prospects

As telemedicine has become more popular and its effectiveness has been proven due to COVID-19, consumer behavior in accessing healthcare is changing.

This changed consumer behavior is expected to continue even after COVID-19 is over, and as a result, demand for EverlyWell services, represented by 'diagnostic kits and digital consultations', is expected to continue to grow.